LIFE SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=602079, encodeId=c4136020e981, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天晚上就外审了，一审两周后收到修稿意见，给了一个半月时间，20来天修回，6天后接受，大概20多天见刊，速度挺快的，编辑很是负责，审稿人提的问题很是专业……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Thu Jun 11 23:05:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时更新中 10.27 submit----with editor 10.29 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228332, encodeId=204e122833224, content=偏重的研究方向：肿瘤学;药学 经验分享：6月21日投稿， 6月23日under review 后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161115/IMG582A66F3DE9742857.jpg, createdBy=d1bd1980807, createdName=安鸠啦-紧紧, createdTime=Fri Jun 24 00:53:03 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112746, encodeId=bdc82112e4649, content=偏重的研究方向：肾脏代谢 经验分享：实时更新中 2.1 submit----with editor 2.2 under review（12h后）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Thu Feb 02 15:33:51 CST 2023, time=2023-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=977636, encodeId=12f49e7636a8, content=请问一下，wb需要原始条带吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaqK7JkDhKVeap5XjibjxTCAuZ4RYribRAiaPlNws0luicXlsXibwgb86VfMWoWXVP8KiatrZgVgSAKcdNsk3C22zunLg/132, createdBy=e2702491564, createdName=张小小小小小丸子, createdTime=Mon Jun 28 17:42:57 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183878, encodeId=77cd21838e82f, content=1.21投稿，目前还是submitted状态…，网上不是说的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Thu Jan 25 14:18:07 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172037, encodeId=ee1321e2037a2, content=最近变慢了？？？怎么好几天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Thu Nov 30 10:28:28 CST 2023, time=2023-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161767, encodeId=f6342161e676b, content=偏重的研究方向：肿瘤学 经验分享：3号开始到现在，都在w i t h e d i t o r，综述，给我个痛快吧，每天看一遍，累了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Mon Oct 09 16:05:07 CST 2023, time=2023-10-09, status=1, ipAttribution=北京)]

2020-06-11 1424056585

审稿速度:1.0 | 投稿命中率:50.0
经验分享：投稿当天晚上就外审了，一审两周后收到修稿意见，给了一个半月时间，20来天修回，6天后接受，大概20多天见刊，速度挺快的，编辑很是负责，审稿人提的问题很是专业……

140 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=602079, encodeId=c4136020e981, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天晚上就外审了，一审两周后收到修稿意见，给了一个半月时间，20来天修回，6天后接受，大概20多天见刊，速度挺快的，编辑很是负责，审稿人提的问题很是专业……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Thu Jun 11 23:05:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时更新中 10.27 submit----with editor 10.29 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228332, encodeId=204e122833224, content=偏重的研究方向：肿瘤学;药学 经验分享：6月21日投稿， 6月23日under review 后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161115/IMG582A66F3DE9742857.jpg, createdBy=d1bd1980807, createdName=安鸠啦-紧紧, createdTime=Fri Jun 24 00:53:03 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112746, encodeId=bdc82112e4649, content=偏重的研究方向：肾脏代谢 经验分享：实时更新中 2.1 submit----with editor 2.2 under review（12h后）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Thu Feb 02 15:33:51 CST 2023, time=2023-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=977636, encodeId=12f49e7636a8, content=请问一下，wb需要原始条带吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaqK7JkDhKVeap5XjibjxTCAuZ4RYribRAiaPlNws0luicXlsXibwgb86VfMWoWXVP8KiatrZgVgSAKcdNsk3C22zunLg/132, createdBy=e2702491564, createdName=张小小小小小丸子, createdTime=Mon Jun 28 17:42:57 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183878, encodeId=77cd21838e82f, content=1.21投稿，目前还是submitted状态…，网上不是说的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Thu Jan 25 14:18:07 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172037, encodeId=ee1321e2037a2, content=最近变慢了？？？怎么好几天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Thu Nov 30 10:28:28 CST 2023, time=2023-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161767, encodeId=f6342161e676b, content=偏重的研究方向：肿瘤学 经验分享：3号开始到现在，都在w i t h e d i t o r，综述，给我个痛快吧，每天看一遍，累了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Mon Oct 09 16:05:07 CST 2023, time=2023-10-09, status=1, ipAttribution=北京)]

2022-11-03 加油！

审稿速度:3.0 | 投稿命中率:50.0
经验分享：实时更新中
10.27 submit----with editor
10.29 under review

57 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=602079, encodeId=c4136020e981, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天晚上就外审了，一审两周后收到修稿意见，给了一个半月时间，20来天修回，6天后接受，大概20多天见刊，速度挺快的，编辑很是负责，审稿人提的问题很是专业……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Thu Jun 11 23:05:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时更新中 10.27 submit----with editor 10.29 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228332, encodeId=204e122833224, content=偏重的研究方向：肿瘤学;药学 经验分享：6月21日投稿， 6月23日under review 后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161115/IMG582A66F3DE9742857.jpg, createdBy=d1bd1980807, createdName=安鸠啦-紧紧, createdTime=Fri Jun 24 00:53:03 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112746, encodeId=bdc82112e4649, content=偏重的研究方向：肾脏代谢 经验分享：实时更新中 2.1 submit----with editor 2.2 under review（12h后）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Thu Feb 02 15:33:51 CST 2023, time=2023-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=977636, encodeId=12f49e7636a8, content=请问一下，wb需要原始条带吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaqK7JkDhKVeap5XjibjxTCAuZ4RYribRAiaPlNws0luicXlsXibwgb86VfMWoWXVP8KiatrZgVgSAKcdNsk3C22zunLg/132, createdBy=e2702491564, createdName=张小小小小小丸子, createdTime=Mon Jun 28 17:42:57 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183878, encodeId=77cd21838e82f, content=1.21投稿，目前还是submitted状态…，网上不是说的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Thu Jan 25 14:18:07 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172037, encodeId=ee1321e2037a2, content=最近变慢了？？？怎么好几天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Thu Nov 30 10:28:28 CST 2023, time=2023-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161767, encodeId=f6342161e676b, content=偏重的研究方向：肿瘤学 经验分享：3号开始到现在，都在w i t h e d i t o r，综述，给我个痛快吧，每天看一遍，累了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Mon Oct 09 16:05:07 CST 2023, time=2023-10-09, status=1, ipAttribution=北京)]

2022-06-24 安鸠啦-紧紧

偏重的研究方向：肿瘤学;药学
经验分享：6月21日投稿， 6月23日under review 后续更新

58 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=602079, encodeId=c4136020e981, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天晚上就外审了，一审两周后收到修稿意见，给了一个半月时间，20来天修回，6天后接受，大概20多天见刊，速度挺快的，编辑很是负责，审稿人提的问题很是专业……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Thu Jun 11 23:05:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时更新中 10.27 submit----with editor 10.29 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228332, encodeId=204e122833224, content=偏重的研究方向：肿瘤学;药学 经验分享：6月21日投稿， 6月23日under review 后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161115/IMG582A66F3DE9742857.jpg, createdBy=d1bd1980807, createdName=安鸠啦-紧紧, createdTime=Fri Jun 24 00:53:03 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112746, encodeId=bdc82112e4649, content=偏重的研究方向：肾脏代谢 经验分享：实时更新中 2.1 submit----with editor 2.2 under review（12h后）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Thu Feb 02 15:33:51 CST 2023, time=2023-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=977636, encodeId=12f49e7636a8, content=请问一下，wb需要原始条带吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaqK7JkDhKVeap5XjibjxTCAuZ4RYribRAiaPlNws0luicXlsXibwgb86VfMWoWXVP8KiatrZgVgSAKcdNsk3C22zunLg/132, createdBy=e2702491564, createdName=张小小小小小丸子, createdTime=Mon Jun 28 17:42:57 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183878, encodeId=77cd21838e82f, content=1.21投稿，目前还是submitted状态…，网上不是说的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Thu Jan 25 14:18:07 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172037, encodeId=ee1321e2037a2, content=最近变慢了？？？怎么好几天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Thu Nov 30 10:28:28 CST 2023, time=2023-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161767, encodeId=f6342161e676b, content=偏重的研究方向：肿瘤学 经验分享：3号开始到现在，都在w i t h e d i t o r，综述，给我个痛快吧，每天看一遍，累了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Mon Oct 09 16:05:07 CST 2023, time=2023-10-09, status=1, ipAttribution=北京)]

2024-01-30 1489114dm38(暂无昵称) 来自四川省

偏重的研究方向：肿瘤学
经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿

27 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=602079, encodeId=c4136020e981, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天晚上就外审了，一审两周后收到修稿意见，给了一个半月时间，20来天修回，6天后接受，大概20多天见刊，速度挺快的，编辑很是负责，审稿人提的问题很是专业……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Thu Jun 11 23:05:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时更新中 10.27 submit----with editor 10.29 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228332, encodeId=204e122833224, content=偏重的研究方向：肿瘤学;药学 经验分享：6月21日投稿， 6月23日under review 后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161115/IMG582A66F3DE9742857.jpg, createdBy=d1bd1980807, createdName=安鸠啦-紧紧, createdTime=Fri Jun 24 00:53:03 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112746, encodeId=bdc82112e4649, content=偏重的研究方向：肾脏代谢 经验分享：实时更新中 2.1 submit----with editor 2.2 under review（12h后）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Thu Feb 02 15:33:51 CST 2023, time=2023-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=977636, encodeId=12f49e7636a8, content=请问一下，wb需要原始条带吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaqK7JkDhKVeap5XjibjxTCAuZ4RYribRAiaPlNws0luicXlsXibwgb86VfMWoWXVP8KiatrZgVgSAKcdNsk3C22zunLg/132, createdBy=e2702491564, createdName=张小小小小小丸子, createdTime=Mon Jun 28 17:42:57 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183878, encodeId=77cd21838e82f, content=1.21投稿，目前还是submitted状态…，网上不是说的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Thu Jan 25 14:18:07 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172037, encodeId=ee1321e2037a2, content=最近变慢了？？？怎么好几天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Thu Nov 30 10:28:28 CST 2023, time=2023-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161767, encodeId=f6342161e676b, content=偏重的研究方向：肿瘤学 经验分享：3号开始到现在，都在w i t h e d i t o r，综述，给我个痛快吧，每天看一遍，累了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Mon Oct 09 16:05:07 CST 2023, time=2023-10-09, status=1, ipAttribution=北京)]

2024-01-02 594624370 来自四川省

偏重的研究方向：细胞生物学
经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂

21 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=602079, encodeId=c4136020e981, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天晚上就外审了，一审两周后收到修稿意见，给了一个半月时间，20来天修回，6天后接受，大概20多天见刊，速度挺快的，编辑很是负责，审稿人提的问题很是专业……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Thu Jun 11 23:05:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时更新中 10.27 submit----with editor 10.29 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228332, encodeId=204e122833224, content=偏重的研究方向：肿瘤学;药学 经验分享：6月21日投稿， 6月23日under review 后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161115/IMG582A66F3DE9742857.jpg, createdBy=d1bd1980807, createdName=安鸠啦-紧紧, createdTime=Fri Jun 24 00:53:03 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112746, encodeId=bdc82112e4649, content=偏重的研究方向：肾脏代谢 经验分享：实时更新中 2.1 submit----with editor 2.2 under review（12h后）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Thu Feb 02 15:33:51 CST 2023, time=2023-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=977636, encodeId=12f49e7636a8, content=请问一下，wb需要原始条带吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaqK7JkDhKVeap5XjibjxTCAuZ4RYribRAiaPlNws0luicXlsXibwgb86VfMWoWXVP8KiatrZgVgSAKcdNsk3C22zunLg/132, createdBy=e2702491564, createdName=张小小小小小丸子, createdTime=Mon Jun 28 17:42:57 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183878, encodeId=77cd21838e82f, content=1.21投稿，目前还是submitted状态…，网上不是说的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Thu Jan 25 14:18:07 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172037, encodeId=ee1321e2037a2, content=最近变慢了？？？怎么好几天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Thu Nov 30 10:28:28 CST 2023, time=2023-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161767, encodeId=f6342161e676b, content=偏重的研究方向：肿瘤学 经验分享：3号开始到现在，都在w i t h e d i t o r，综述，给我个痛快吧，每天看一遍，累了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Mon Oct 09 16:05:07 CST 2023, time=2023-10-09, status=1, ipAttribution=北京)]

2023-02-02 ms9000001599932088 来自上海

偏重的研究方向：肾脏代谢
经验分享：实时更新中
2.1 submit----with editor
2.2 under review（12h后）

74 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=602079, encodeId=c4136020e981, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天晚上就外审了，一审两周后收到修稿意见，给了一个半月时间，20来天修回，6天后接受，大概20多天见刊，速度挺快的，编辑很是负责，审稿人提的问题很是专业……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Thu Jun 11 23:05:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时更新中 10.27 submit----with editor 10.29 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228332, encodeId=204e122833224, content=偏重的研究方向：肿瘤学;药学 经验分享：6月21日投稿， 6月23日under review 后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161115/IMG582A66F3DE9742857.jpg, createdBy=d1bd1980807, createdName=安鸠啦-紧紧, createdTime=Fri Jun 24 00:53:03 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112746, encodeId=bdc82112e4649, content=偏重的研究方向：肾脏代谢 经验分享：实时更新中 2.1 submit----with editor 2.2 under review（12h后）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Thu Feb 02 15:33:51 CST 2023, time=2023-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=977636, encodeId=12f49e7636a8, content=请问一下，wb需要原始条带吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaqK7JkDhKVeap5XjibjxTCAuZ4RYribRAiaPlNws0luicXlsXibwgb86VfMWoWXVP8KiatrZgVgSAKcdNsk3C22zunLg/132, createdBy=e2702491564, createdName=张小小小小小丸子, createdTime=Mon Jun 28 17:42:57 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183878, encodeId=77cd21838e82f, content=1.21投稿，目前还是submitted状态…，网上不是说的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Thu Jan 25 14:18:07 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172037, encodeId=ee1321e2037a2, content=最近变慢了？？？怎么好几天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Thu Nov 30 10:28:28 CST 2023, time=2023-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161767, encodeId=f6342161e676b, content=偏重的研究方向：肿瘤学 经验分享：3号开始到现在，都在w i t h e d i t o r，综述，给我个痛快吧，每天看一遍，累了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Mon Oct 09 16:05:07 CST 2023, time=2023-10-09, status=1, ipAttribution=北京)]

2021-06-28 张小小小小小丸子

请问一下，wb需要原始条带吗？

74 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=602079, encodeId=c4136020e981, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天晚上就外审了，一审两周后收到修稿意见，给了一个半月时间，20来天修回，6天后接受，大概20多天见刊，速度挺快的，编辑很是负责，审稿人提的问题很是专业……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Thu Jun 11 23:05:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时更新中 10.27 submit----with editor 10.29 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228332, encodeId=204e122833224, content=偏重的研究方向：肿瘤学;药学 经验分享：6月21日投稿， 6月23日under review 后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161115/IMG582A66F3DE9742857.jpg, createdBy=d1bd1980807, createdName=安鸠啦-紧紧, createdTime=Fri Jun 24 00:53:03 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112746, encodeId=bdc82112e4649, content=偏重的研究方向：肾脏代谢 经验分享：实时更新中 2.1 submit----with editor 2.2 under review（12h后）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Thu Feb 02 15:33:51 CST 2023, time=2023-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=977636, encodeId=12f49e7636a8, content=请问一下，wb需要原始条带吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaqK7JkDhKVeap5XjibjxTCAuZ4RYribRAiaPlNws0luicXlsXibwgb86VfMWoWXVP8KiatrZgVgSAKcdNsk3C22zunLg/132, createdBy=e2702491564, createdName=张小小小小小丸子, createdTime=Mon Jun 28 17:42:57 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183878, encodeId=77cd21838e82f, content=1.21投稿，目前还是submitted状态…，网上不是说的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Thu Jan 25 14:18:07 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172037, encodeId=ee1321e2037a2, content=最近变慢了？？？怎么好几天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Thu Nov 30 10:28:28 CST 2023, time=2023-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161767, encodeId=f6342161e676b, content=偏重的研究方向：肿瘤学 经验分享：3号开始到现在，都在w i t h e d i t o r，综述，给我个痛快吧，每天看一遍，累了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Mon Oct 09 16:05:07 CST 2023, time=2023-10-09, status=1, ipAttribution=北京)]

2024-01-25 biocell160 来自贵州省

1.21投稿，目前还是submitted状态…，网上不是说的很快吗？

18 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=602079, encodeId=c4136020e981, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天晚上就外审了，一审两周后收到修稿意见，给了一个半月时间，20来天修回，6天后接受，大概20多天见刊，速度挺快的，编辑很是负责，审稿人提的问题很是专业……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Thu Jun 11 23:05:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时更新中 10.27 submit----with editor 10.29 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228332, encodeId=204e122833224, content=偏重的研究方向：肿瘤学;药学 经验分享：6月21日投稿， 6月23日under review 后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161115/IMG582A66F3DE9742857.jpg, createdBy=d1bd1980807, createdName=安鸠啦-紧紧, createdTime=Fri Jun 24 00:53:03 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112746, encodeId=bdc82112e4649, content=偏重的研究方向：肾脏代谢 经验分享：实时更新中 2.1 submit----with editor 2.2 under review（12h后）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Thu Feb 02 15:33:51 CST 2023, time=2023-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=977636, encodeId=12f49e7636a8, content=请问一下，wb需要原始条带吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaqK7JkDhKVeap5XjibjxTCAuZ4RYribRAiaPlNws0luicXlsXibwgb86VfMWoWXVP8KiatrZgVgSAKcdNsk3C22zunLg/132, createdBy=e2702491564, createdName=张小小小小小丸子, createdTime=Mon Jun 28 17:42:57 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183878, encodeId=77cd21838e82f, content=1.21投稿，目前还是submitted状态…，网上不是说的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Thu Jan 25 14:18:07 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172037, encodeId=ee1321e2037a2, content=最近变慢了？？？怎么好几天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Thu Nov 30 10:28:28 CST 2023, time=2023-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161767, encodeId=f6342161e676b, content=偏重的研究方向：肿瘤学 经验分享：3号开始到现在，都在w i t h e d i t o r，综述，给我个痛快吧，每天看一遍，累了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Mon Oct 09 16:05:07 CST 2023, time=2023-10-09, status=1, ipAttribution=北京)]

2023-11-30 ms4000000245921040 来自北京

最近变慢了？？？怎么好几天了还是submitted

12 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=602079, encodeId=c4136020e981, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：投稿当天晚上就外审了，一审两周后收到修稿意见，给了一个半月时间，20来天修回，6天后接受，大概20多天见刊，速度挺快的，编辑很是负责，审稿人提的问题很是专业……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Thu Jun 11 23:05:28 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：实时更新中 10.27 submit----with editor 10.29 under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油！, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228332, encodeId=204e122833224, content=偏重的研究方向：肿瘤学;药学 经验分享：6月21日投稿， 6月23日under review 后续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161115/IMG582A66F3DE9742857.jpg, createdBy=d1bd1980807, createdName=安鸠啦-紧紧, createdTime=Fri Jun 24 00:53:03 CST 2022, time=2022-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112746, encodeId=bdc82112e4649, content=偏重的研究方向：肾脏代谢 经验分享：实时更新中 2.1 submit----with editor 2.2 under review（12h后）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230202/9f2a35a055c54641b1cd58c74119085d/e91c6c98ddcb41beabc093c039407752.jpg, createdBy=00a85537138, createdName=ms9000001599932088, createdTime=Thu Feb 02 15:33:51 CST 2023, time=2023-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=977636, encodeId=12f49e7636a8, content=请问一下，wb需要原始条带吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaqK7JkDhKVeap5XjibjxTCAuZ4RYribRAiaPlNws0luicXlsXibwgb86VfMWoWXVP8KiatrZgVgSAKcdNsk3C22zunLg/132, createdBy=e2702491564, createdName=张小小小小小丸子, createdTime=Mon Jun 28 17:42:57 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183878, encodeId=77cd21838e82f, content=1.21投稿，目前还是submitted状态…，网上不是说的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Thu Jan 25 14:18:07 CST 2024, time=2024-01-25, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2172037, encodeId=ee1321e2037a2, content=最近变慢了？？？怎么好几天了还是submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad208615216, createdName=ms4000000245921040, createdTime=Thu Nov 30 10:28:28 CST 2023, time=2023-11-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161767, encodeId=f6342161e676b, content=偏重的研究方向：肿瘤学 经验分享：3号开始到现在，都在w i t h e d i t o r，综述，给我个痛快吧，每天看一遍，累了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLq9qicTF5QNWGwDWEGu4UJTFXWabibYowE3lXECcPLCbLiaUuk73vtAZZEZ92AaV4W4d2CicGicXByDJA/132, createdBy=ce9b2265216, createdName=CH常, createdTime=Mon Oct 09 16:05:07 CST 2023, time=2023-10-09, status=1, ipAttribution=北京)]

2023-10-09 CH常来自北京

偏重的研究方向：肿瘤学
经验分享：3号开始到现在，都在w i t h e d i t o r，综述，给我个痛快吧，每天看一遍，累了

26 10

展开10条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务